MUC5AC and central nervous system cancer: While there is a paucity of studies that analyze mucin levels in serum, tissue, and CSF samples in glioma patients, there are malignancy settings that have employed mucins as biomarkers in several or all of these biofluids, indicating that such an approach is feasible (Table 2).